"Antiprotozoal Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that are destructive to protozoans.
| Descriptor ID |
D000981
|
| MeSH Number(s) |
D27.505.954.122.250.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antiprotozoal Agents".
Below are MeSH descriptors whose meaning is more specific than "Antiprotozoal Agents".
This graph shows the total number of publications written about "Antiprotozoal Agents" by people in this website by year, and whether "Antiprotozoal Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 2 | 3 | 5 |
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 1 | 3 |
| 2014 | 0 | 1 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 2 | 2 | 4 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antiprotozoal Agents" by people in Profiles.
-
Diptyanusa A, Sari IP. Treatment of human intestinal cryptosporidiosis: A review of published clinical trials. Int J Parasitol Drugs Drug Resist. 2021 12; 17:128-138.
-
Thulasi P, Saeed HN, Rapuano CJ, Hou JH, Appenheimer AB, Chodosh J, Kang JJ, Morrill AM, Vyas N, Zegans ME, Zuckerman R, Tu EY. Oral Miltefosine as Salvage Therapy for Refractory Acanthamoeba Keratitis. Am J Ophthalmol. 2021 03; 223:75-82.
-
Schwebke JR, Morgan FG, Koltun W, Nyirjesy P. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis. Am J Obstet Gynecol. 2017 12; 217(6):678.e1-678.e9.
-
Singh SK, Prasad KN, Singh AK, Gupta KK, Singh A, Tripathi M, Gupta RK. Adhesion molecules, chemokines and matrix metallo-proteinases response after albendazole and albendazole plus steroid therapy in swine neurocysticercosis. Exp Parasitol. 2017 Nov; 182:1-8.
-
Hillier SL, Nyirjesy P, Waldbaum AS, Schwebke JR, Morgan FG, Adetoro NA, Braun CJ. Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial. Obstet Gynecol. 2017 08; 130(2):379-386.
-
Pascual J, Laoteppitaks C. Unique Rash After Beach Vacation. J Emerg Med. 2017 06; 52(6):878-879.
-
Danaher M, Shanahan C, Butler F, Evans R, O'Sullivan D, Glynn D, Camon T, Lawlor P, O'Keeffe M. Risk-based approach to developing a national residue sampling plan for testing under European Union regulation for veterinary medicinal products and coccidiostat feed additives in domestic animal production. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2016 Jul; 33(7):1155-65.
-
Meites E, Gaydos CA, Hobbs MM, Kissinger P, Nyirjesy P, Schwebke JR, Secor WE, Sobel JD, Workowski KA. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections. Clin Infect Dis. 2015 Dec 15; 61 Suppl 8:S837-48.
-
Sobel R, Sobel JD. Metronidazole for the treatment of vaginal infections. Expert Opin Pharmacother. 2015 May; 16(7):1109-15.
-
Paulish-Miller TE, Augostini P, Schuyler JA, Smith WL, Mordechai E, Adelson ME, Gygax SE, Secor WE, Hilbert DW. Trichomonas vaginalis metronidazole resistance is associated with single nucleotide polymorphisms in the nitroreductase genes ntr4Tv and ntr6Tv. Antimicrob Agents Chemother. 2014 May; 58(5):2938-43.